Orexin-1 receptor co-localizes with pancreatic hormones in islet cells and modulates the outcome of streptozotocin-induced diabetes mellitus

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Adeghate, Ernest ^a   Fernandez Cabezudo, Maria ^a   Hameed, Rashed ^a   El Hasasna, Hussain ^a   El Wasila, Mohamed ^a   Abbas, Tariq ^b   Al Ramadi, Basel ^a  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b Veterinary Laboratory   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON; GLUCOSE; INSULIN; OREXIN 1 RECEPTOR; PANCREAS HORMONE; STREPTOZOCIN; G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE RECEPTOR; OREXIN RECEPTORS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENDOCRINE CELL; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INSULIN DEPENDENT DIABETES MELLITUS; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OUTCOME ASSESSMENT; PANCREAS ISLET CELL; PROTEIN EXPRESSION; RAT; TIME; WESTERN BLOTTING; WILD TYPE; WISTAR RAT; ANIMAL; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PANCREAS ISLET; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA; MUS; RATTUS; RATTUS NORVEGICUS;

ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; GLUCAGON; IMMUNOHISTOCHEMISTRY; INSULIN; ISLETS OF LANGERHANS; MALE; PANCREATIC HORMONES; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; STREPTOZOCIN;

EID: 77649125269     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008587     Document Type: Article

References (41)

1. Matsuki T, Sakurai T (2008) Orexins and Orexin Receptors: From molecules to integrative physiology. Results Probl Cell Differ 46: 27-55.
2. Sinton CM, McCarley RW (2004) Neurophysiological mechanisms of sleep and wakefulness: a question of balance. Semin Neurol 24: 211-223.
3. Yamada H, Okumura T, Motomura W, Kobayashi Y, Kohgo Y (2000) Inhibition of food intake by central injection of anti-orexin antibody in fasted rats. Biochem Biophys Res Comm 267: 527-531.
4. Dhillo WS (2007) Appetite Regulation: an overview. Thyroid 17: 433-445.
5. Harrold JA, Halford JC (2006) The hypothalamus and obesity. Recent Patents CNS Drug Discov 1: 305-314.
6. Kiwaki K, Kotz CM, Wang C, Lanningham-Foster L, Levine JA (2004) Orexin A (hypocretin 1) injected into hypothalamic paraventricular nucleus and spontaneous physical activity in rats. Am J Physiol Endocrinol Metab 286: E551-E559.
7. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli R, et al. (1998) Orexins and orexin receptors: a family of hypothalamic neuropeptides and G-protein coupled receptors that regulate feeding behaviour. Cell 92: 573-585.
8. Bernardis LL, Bellinger LL (1993) The lateral hypothalamic area revisited: neuroanatomy, body weight regulation, Neuroendocrinology and metabolism. Neurosci Behav Rev 17: 141-193.
9. Hara J, Beuckmann CT, Nambu T, Willie JT, Chemelli RM, et al. (2001) Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia and obesity. Neuron 30: 345-354.
10. Voisin T, Rouet-Benzineb P, Reuter N, Laburthe M (2003) Orexins and their receptors: structural aspects and role in peripheral tissues. Cell Mol Life Sci 60: 72-87.
11. Kukkonen JP, Holmqvist T, Ammoun S, Akerman KE (2002) Functions of the orexinergic/hypocretinergic system. Am J Physiol Cell Physiol 283: C1567-1591.
12. Kirschgessner AL, Liu M-T (1999) Orexin synthesis and response in the gut. Neuron 24: 941-951.
13. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, et al. (2001) Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol 435: 6-25.
14. Bray GA (1984) Hypothalamic and genetic obesity: an appraisal of the autonomic hypothesis and the endocrine hypothesis. J Obesity 8: 119-137.
15. Bingham S, Davey PT, Babbs AJ, Irving EA, Sammons MJ, et al. (2001) Orexin-A, an hypothalamic peptide with analgesic properties. Pain 92: 81-90.
16. Jöhren O, Neidert SJ, Kummer M, Dendorfer A, Dominiak P (2001) Preproorexin and orexin receptor mRNAs are differentially expressed in peripheral tissues of male and female rats. Endocrinology 142: 3324-3331.
17. Randeva HS, Karteris E, Grammatopoulos D, Hillhouse EW (2001) Expression of orexin-A and functional orexin type 2 receptors in the human adult adrenals: implications for adrenal function and energy homeostasis. J Clin Endocrinol Metab 86: 4808-4813.
18. Ehrstrom M, Naslund E, Ma J, Kirchgessner AL, Hellstrom PM (2003) Physiological regulation and NO-dependent inhibition of migrating myoelectric complex in the rat small bowel by OXA. Am J Physiol Gastrointest Liver Physiol 285: G688-695.
19. Russo F, Pavone LM, Tafuri S, Avallone L, Staiano N, et al. (2008) Expression of orexin A and its receptor in the bovine urethroprostatic complex. Anat Rec 291: 169-174.
20. Naslund E, Ehrstrom M, Ma J, Hellstrom PM, Kirchgessner AL (2002) Localization and effects of orexin on fasting motility in the rat duodenum. Am J Physiol Gastrointest Liver Physiol 282: G470-479.
21. Adeghate E, Hameed RS (2005) Immunolocalization of orexin-1 receptor in the pancreas of normal and diabetic rats. Biogenic Amines 19: 347-355.
22. Adeghate E, Ponery AS, Pallot DJ, Singh J (2000) Distribution of neurotransmitters and their effects on glucagon secretion from the in vitro normal and diabetic pancreatic tissues. Tissue Cell 32: 266-274.
23. Zamboni L, de Martino C (1967) Buffered picric acid-formaldehyde: a new rapid fixation for electron microscopy. J Cell Biol 35: 148A.
24. Giroix MH, Vesco L, Portha B (1993) Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulindependent diabetes. Endocrinology 132: 815-822.
25. Baumann CR, Bassetti CL, Valko PO, Haybaeck J, Keller M, et al. (2009) Loss of hypocretin (orexin) neurons with traumatic brain injury. Ann Neurol 66: 555-559.
26. Adeghate E, Ponery AS (2004) Diabetes mellitus influences the degree of colocalization of calcitonin-gene-related peptide with insulin and somatostatin. Pancreas 29: 311-319.
27. 1R for orexins and drives apoptosis: a novel mechanism. FASEB J 22: 1993-2002.
28. Laburthe M, Voisin T, El Firar A (2009) Orexins/hypocretins and OX receptors in apoptosis: a minireview. Acta Physiol (Oxf) [Epub ahead of print].
29. 1R-driven apoptosis. FASEB J 23: 4069-4080.
30. Zhang XF, Tan BKH (2000) Effect of an ethanolic extract of gynura procumbens on serum glucose, cholesterol and triglyceride levels in normal and streptozotocin-induced diabetic rats. Singapore Med J 41: 9-13.
31. Miyasaka K, Masuda M, Kanai S, Sato N, Kurosawa M, et al. (2002) Central Orexin-A stimulates pancreatic exocrine secretion via the vagus. Pancreas 25: 400-404.
32. Mondal MS, Nakazato M, Date Y, Murakami N, Yanagisawa M, et al. (1999) Widespread distribution of orexin in rat brain and its regulation upon fasting. Biochem Biophys Res Comm 256: 495-499.
33. Lu X-Y, Bagnol D, Burke S, Akil H, Watson SJ (2000) Differential distribution and regulation of OX1 and OX2 orexin/hypocretin receptor messenger RNA in the brain upon fasting. Horm Behav 37: 335-344.
34. Madsen OD, Jensen J, Blume N, Petersen HV, Lund K, et al. (1996) Pancreatic development and maturation of the islet B cell. Studies of pluripotent islet cultures. Eur J Biochem 242: 435-445.
35. Adeghate E, Ponery AS, Pallot DJ, Singh J (2001) Distribution of vasoactive intestinal polypeptide, neuropeptide-Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats. Peptides 22: 99-107.
36. Nowak KW, Mackowiak P, Switonska MM, Fabis M, Malendowicz LK (2000) Acute orexin effects on insulin secretion in the rat: in vivo and in vitro studies. Life Sci 66: 449-454.
37. Ouedraogo R, Naslund E, Kirchgessner AL (2003) Glucose regulates the release of Orexin A from the endocrine pancreas. Diabetes 52: 111-117.
38. Lambert DG, Atkins TW (1989) Effects of islet hormones on insulin secretion from cloned B cell lines, HIT-T15 and RINm5F. J Endocrinol 121: 479-485.
39. Katsuura G, Asakawa A, Inui A (2002) Roles of pancreatic polypeptide in regulation of food intake. Peptides 23: 323-329.
40. Adeghate E (2004) Molecular and Cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review. Mol Cell Biochem 261: 187-191.
41. Kamboj SS, Vasishta RK, Sandhir R (2009) N-acetylcysteine Inhibits Hyperglycemia-induced Oxidative Stress and Apoptosis Markers in Diabetic Neuropathy. J Neurochem [Epub ahead of print].